Hakim Yadi
CEO

Closed Loop Medicine develops personalized digital healthcare solutions that integrate dose-optimized drug therapy with digital therapeutics to enhance treatment adherence and patient outcomes. The platform addresses the inefficiencies of traditional healthcare delivery, which often leads to suboptimal management of chronic conditions and increased costs for payors.
Raised to date
$28.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.






CEO
Traditional healthcare delivery often results in suboptimal management of chronic conditions due to the one-size-fits-all approach to medication and treatment. This can lead to poorer patient outcomes, increased healthcare costs, and lost value across the healthcare system.
Closed Loop Medicine develops personalized digital healthcare solutions that combine dose-optimized drug therapy with digital therapeutics (DTx) to improve treatment adherence and patient outcomes. Their platform integrates a software as a medical device (SaMD) platform with traditional therapeutics, creating a combination product that enables personalized, optimized dosing. By linking remote monitoring with intervention, Closed Loop Medicine aims to improve drug effectiveness and provide integrated treatment solutions that support patients in monitoring, tracking, and improving their health. The platform is designed to be safe, protectable, and scalable, creating value for patients, healthcare professionals, and health systems.
Closed Loop Medicine targets pharmaceutical companies, payors, and healthcare providers seeking to improve outcomes for patients with chronic diseases through personalized medicine solutions.